Ionis Pharmaceuticals Inc (IONS)
41.60
-0.24
(-0.59%)
USD |
NASDAQ |
Apr 26, 15:57
Ionis Pharmaceuticals Price: 41.60 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 42.54 | 42.72 | 41.58 | 41.84 | 1.141M |
Apr 24, 2024 | 41.97 | 42.72 | 41.59 | 42.45 | 728605.0 |
Apr 23, 2024 | 41.28 | 42.25 | 40.90 | 41.84 | 631237.0 |
Apr 22, 2024 | 40.84 | 41.83 | 40.58 | 41.07 | 705230.0 |
Apr 19, 2024 | 40.88 | 41.16 | 40.38 | 40.68 | 846040.0 |
Apr 18, 2024 | 41.00 | 41.53 | 40.77 | 40.81 | 990649.0 |
Apr 17, 2024 | 41.37 | 41.60 | 40.76 | 40.91 | 1.176M |
Apr 16, 2024 | 41.55 | 42.01 | 41.42 | 41.54 | 1.101M |
Apr 15, 2024 | 41.73 | 42.05 | 41.26 | 41.55 | 789558.0 |
Apr 12, 2024 | 42.35 | 42.55 | 41.47 | 41.74 | 829857.0 |
Apr 11, 2024 | 43.10 | 43.30 | 42.05 | 42.50 | 869815.0 |
Apr 10, 2024 | 43.29 | 43.38 | 42.48 | 42.94 | 825859.0 |
Apr 09, 2024 | 42.69 | 43.04 | 42.50 | 42.83 | 847529.0 |
Apr 08, 2024 | 43.44 | 43.44 | 42.21 | 42.24 | 868857.0 |
Apr 05, 2024 | 42.63 | 43.38 | 42.21 | 43.22 | 596959.0 |
Apr 04, 2024 | 43.96 | 44.07 | 42.81 | 42.83 | 1.104M |
Apr 03, 2024 | 42.73 | 43.83 | 42.68 | 43.78 | 1.457M |
Apr 02, 2024 | 43.51 | 43.81 | 42.64 | 43.00 | 906989.0 |
Apr 01, 2024 | 43.31 | 44.08 | 42.88 | 43.94 | 699355.0 |
Mar 28, 2024 | 44.95 | 44.95 | 43.32 | 43.35 | 1.999M |
Mar 27, 2024 | 44.56 | 44.85 | 43.83 | 44.66 | 886196.0 |
Mar 26, 2024 | 44.35 | 44.75 | 43.59 | 44.11 | 935555.0 |
Mar 25, 2024 | 42.66 | 43.99 | 42.66 | 43.91 | 875159.0 |
Mar 22, 2024 | 42.56 | 42.93 | 42.33 | 42.72 | 752497.0 |
Mar 21, 2024 | 43.00 | 43.97 | 42.64 | 42.75 | 691454.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
25.61
Minimum
Dec 01 2021
74.73
Maximum
Apr 26 2019
46.65
Average
44.24
Median
Price Benchmarks
Madrigal Pharmaceuticals Inc | 193.32 |
Viking Therapeutics Inc | 74.63 |
Alnylam Pharmaceuticals Inc | 144.06 |
Akero Therapeutics Inc | 19.74 |
89bio Inc | 8.28 |
Price Related Metrics
PS Ratio | 7.562 |
PEG Ratio | -0.4677 |
Price to Book Value | 15.68 |
Earnings Yield | -6.15% |
Market Cap | 6.063B |
PEGY Ratio | -0.4677 |